Wall Street Veteran Barbara Ryan Joins FTI Consulting
Key Appointment Bolsters the Firm's Healthcare and Life Sciences Financial
WEST PALM BEACH, Fla., April 2, 2013
WEST PALM BEACH, Fla., April 2, 2013 /PRNewswire/ --FTI Consulting, Inc.
(NYSE: FCN), the global business advisory firm dedicated to helping
organizations protect and enhance their enterprise value, today announced that
Barbara Ryan has been appointed Managing Director in the firm's Strategic
The addition of Ms. Ryan, a recognized biopharmaceutical industry expert and
veteran Wall Street professional, further strengthens the practice's financial
communications capabilities and deepens its expertise in the healthcare and
life sciences sector. In her new role, Ms. Ryan will also support the firm's
healthcare and life sciences transactions communications and crisis
communications offerings. She will be based in New York.
Ms. Ryan brings more than 30 years of Wall Street experience and financial
expertise, with a focus in the biopharmaceutical sector, to FTI Consulting.
She joins the firm from Deutsche Bank, where she held the position of Managing
Director and Head of the Pharmaceutical Research Team for the past 20 years.
In this role, Ms. Ryan published pharmaceutical research, led the firm's
annual healthcare conference and conducted extensive marketing activities with
institutional clients. She also served as the lead analyst on several
high-profile initial public offerings. Prior to joining Deutsche Bank, Ms.
Ryan held pharmaceutical analyst positions at Prudential Securities and Bear
Sterns. Ms. Ryan frequently is a guest contributor to CNBC.
"Barbara is an exciting addition to our thriving healthcare and life sciences
sector," said Edward Reilly, Global Chief Executive Officer of the FTI
Consulting Strategic Communications practice. "Barbara is a well-known and
well-respected voice in the healthcare industry with a deep understanding of
how investors think about and value stocks. Our clients will undoubtedly
benefit from her valuable perspective and insight as they face critical times
of corporate growth and transformation."
Ms. Ryan added, "FTI Consulting is a clear leader in healthcare strategic
communications, and I am excited to join such a dynamic and growing practice.
I look forward to utilizing my many years of experience on Wall Street
covering the pharmaceutical industry to further advance the firm's healthcare
and life sciences capital markets offering."
Ms. Ryan currently serves on the Pharmaceutical Executive Editorial Advisory
Board, as well as on the Healthcare Advisory Board of the Executive Council of
New York. She also is the Chair of the Board of Trustees of the Villa Maria
Education Center in Stamford, Conn. Ms. Ryan frequently is quoted in the press
as a recognized healthcare industry expert in addition to appearing as a guest
lecturer at top university M.B.A. and Executive Education programs, including
Columbia University and the University of California at Berkeley. She studied
finance and economics at the University of Massachusetts.
About FTI Consulting
FTI Consulting, Inc. is a global business advisory firm dedicated to helping
organizations protect and enhance enterprise value in an increasingly complex
legal, regulatory and economic environment. With more than 3,900 employees
located in 24 countries, FTI Consulting professionals work closely with
clients to anticipate, illuminate and overcome complex business challenges in
areas such as investigations, litigation, mergers and acquisitions, regulatory
issues, reputation management, strategic communications and restructuring. The
Company generated $1.58 billion in revenues during fiscal year 2012. More
information can be found at www.fticonsulting.com.
SOURCE FTI Consulting, Inc.
Contact: Investor Contact, Mollie Hawkes, +1.617.747.1791,
email@example.com, Media Contact, Ed Harnaga, +1.212.850.5606,
Press spacebar to pause and continue. Press esc to stop.